Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)Products & Services: a) Stem Cell R&D: Stem Cell Research & Therapy, Regenerative Medicine, Bio-artificial organ scaffolds development, nano-biotechnology, Nano-formulation of cancer Drugs, Molecular genetics, and Molecular virology, Stem cell and Cord blood banking...
Samsrita Labs Limited has announced its 29th Annual General Meeting (AGM) will be held virtually on Monday, August 25, 2025, at 11:00 a.m. via video conferencing. Shareholders can transact business as outlined in the AGM Notice. Electronic copies of the notice and annual report have been sent to registered emails...
Samsrita Labs has issued a clarification regarding a recent preferential allotment of shares. Due to a typographical error, the previously announced number of shares was incorrect. The company will now allot 33,91,000 equity shares of Rs. 10 each, totaling Rs. 3.391 Cr, to Non-Promoters on a preferential basis for cash...
Samsrita Labs Limited has announced the publication of its financial results for the quarter ended June 30, 2025, in leading newspapers. The Board of Directors approved these results at their meeting on July 18, 2025. Shareholders and investors can access the complete financial results, along with a Quick Response Code,...
Samsrita Labs Limited has announced a compliance certificate from its registrar and transfer agent confirming that no securities were dematerialized or rematerialized during the quarter. This indicates stability in the shareholding pattern with no changes through electronic share transfers in this period. The update reassures investors about the status of...
Samsrita Labs Limited has announced the resignation of Duggina Lakshmi Jyothsna from her role as Company Secretary & Compliance Officer due to personal reasons. She has stepped down with immediate effect and confirmed no other material reasons for her departure. The company will proceed with the necessary formalities to notify...
